Human Technopole is now an Associate Partner of LifeTime, the pan-European research initiative that aims to revolutionise healthcare by tracking and understanding human diseases at single cell resolution to transform patients’ care and the sustainability of healthcare systems.
Joining the LifeTime community is an important opportunity for Human Technopole to build a strategic network of relevant European partners that share our ambition and goals.
Human Technopole’s mission is fully aligned with LifeTime’s overarching aim to tackle complex human diseases. Specifically, the three defining pillars of LifeTime (single-cell multiomics, organoids and machine learning-based deconvolution) are represented in HT by the close integration of Centres and Core Facilities featuring leading expertise in these fields.
Together with the University of Milan, the European Institute of Oncology (IEO) and the Sacco Hospital, Human Technopole is already part of the Italian branch of the initiative Lifetime for COVID19, which for the upcoming two years will be led by the Head of our Research Centre for Neurogenomics, Prof. Giuseppe Testa.
The LifeTime consortium gathers over 120 leading scientists from over 90 European research institutes. The University of Milan is the Italian partner of the consortium and other Italian associate partners include the European Institute of Oncology, Fondazione Istituto FIRC di Oncologia Molecolare, the Institute for Biomedical Technologies and the Institute of Photonics and Nanotechnologies of the Italian National Research Council as well as many prominent Italian universities.
Two research projects from Human Technopole have won the Fondazione Telethon and Cariplo grant to uncover the genetic and molecular mechanisms of acute myeloid leukemia and congenital adrenal hyperplasia. The projects, led by Alice Giustacchini (Group Leader of Genomics) and Emanuele Villa and Nicolò Caporale (Testa Group, Neurogenomics), have been respectively funded with €230,000 and €250,000.
Two Human Technopole researchers have been awarded the Marie Curie postdoctoral fellowship, one of the most prestigious fellowships for early career researchers: Dr. Carlos Jiménez and Dr. Albert Navarro Gallinad. Dr. Navarro Gallinad’s research project, presented today on National Women’s Health Day, will investigate the environmental risks faced by pregnant women by analysing almost 1,000,000 births in Lombardy over the last twelve years. Dr. Jiménez will study how the spatial arrangement of nuclear proteins contributes to optimal cell functioning.
Three young scientists from Human Technopole have, for the first time since its foundation, obtained a doctoral degree while pursuing their research within the institute: Alessandro Vinceti, Davide Castaldi, and Marco Tullio Rigoli, all enrolled in the systems medicine programme of the European School of Molecular Medicine (SEMM).
Milan also means research, and this year Human Technopole is taking part in the city’s promotional campaign for the Milan Design Week, which will take place from 15 to 21 April 2024.
Human Technopole’s Director Marino Zerial was invited last week to give the Lectio Magistralis during the inauguration ceremony of University of Genoa’s academic year 2023-2024.
Manage Cookie Consent
This website uses technical cookies to provide you with a better browsing experience and, subject to your consent, profiling cookies to offer you information and advertising in line with your preferences. For more details, you can consult our cookie policy by clicking on the link below, or set your preferences by clicking "set preferences". By selecting "accept cookies" you consent to the use of all types of cookies while you can revoke your consent by clicking on "refuse". By deciding to refuse or closing the banner, only the technical cookies necessary for the correct functioning of the site will be activated.
Technical cookies (required)
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Third party cookies for statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Third party cookies for profiling
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.